You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Jakafi®

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelomonocytic Leukemia Trial in United States (Ruxolitinib)

Completed
Has Results
  • Myelomonocytic Leukemia
  • Tampa, Florida
  • +5 more
Sep 9, 2022

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Untreated Chronic Lymphocytic Leukemia Trial in Houston (Ruxolitinib,

Completed
Has Results
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Untreated Chronic Lymphocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2021

COVID-19 Trial (Ruxolitinib)

Withdrawn
  • COVID-19
  • (no location specified)
Mar 3, 2021

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Acute Lymphoblastic Leukemia, ALL, Childhood, ALL Trial in Chicago (Ruxolitinib, Cyclophosphamide, Cytarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
Sep 14, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Biospecimen Collection
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2023

Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)

Recruiting
  • Myeloproliferative Neoplasms
  • Herston, Queensland, Australia
  • +22 more
Jun 30, 2023

Multiple Myeloma Trial in United States (Ruxolitinib Oral Tablet [Jakafi], Lenalidomide, Methylprednisolone)

Recruiting
  • Multiple Myeloma
  • Ruxolitinib Oral Tablet [Jakafi]
  • +2 more
  • Alhambra, California
  • +12 more
Apr 18, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Duarte (procedure, drug, other)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)

Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 21, 2022

Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)

Not yet recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Boston, Massachusetts
  • +2 more
Nov 24, 2020

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Recurrent DLBCL, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Bethesda, Rochester, Omaha

Completed
Has Results
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +3 more
  • Laboratory Biomarker Analysis
  • Ruxolitinib Phosphate
  • Bethesda, Maryland
  • +2 more
Jul 7, 2021

Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +36 more
Jan 13, 2023

Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)

Terminated
  • Steroid-Refractory Acute Graft Versus Host Disease
  • Birmingham, Alabama
  • +47 more
Jan 22, 2023

COVID-19 Trial (Ruxolitinib, Peripheral blood draw)

Withdrawn
  • COVID-19
  • (no location specified)
May 19, 2020

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Graft-versus-host Disease (GVHD) Trial in United States (Ruxolitinib, Prednisone or methylprednisolone)

Completed
Has Results
  • Graft-versus-host Disease (GVHD)
  • Tucson, Arizona
  • +37 more
Oct 28, 2021

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in Memphis (Palbociclib Oral

Terminated
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • Palbociclib Oral Capsule
  • +6 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 28, 2020

Cancer, Hematological Malignancy Trial in New York (Pembrolizumab, Ruxolitinib)

Withdrawn
  • Cancer
  • Hematological Malignancy
  • New York, New York
    New York University School of Medicine
May 26, 2020

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)

Terminated
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Phoenix, Arizona
  • +25 more
Oct 21, 2021

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Neutrophilic Leukemia Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Neutrophilic Leukemia
  • Laboratory Biomarker Analysis
  • +3 more
  • Palo Alto, California
  • +6 more
Oct 22, 2020

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in United States (PU-H71, Ruxolitinib)

Terminated
  • Myelofibrosis
  • +3 more
  • New Haven, Connecticut
  • +9 more
Oct 19, 2020